Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 5.238.608.177.076.05

What is the latest Working Capital/Sales ratio of PIRAMAL PHARMA ?

The latest Working Capital/Sales ratio of PIRAMAL PHARMA is 5.23 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20255.23
Mar20248.60
Mar20238.17
Mar20227.07
Mar20216.05

How is Working Capital/Sales of PIRAMAL PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 5.23
-39.19
Mar2024 8.6
5.26
Mar2023 8.17
15.56
Mar2022 7.07
16.86
Mar2021 6.05 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Working Capital/Sales ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹23,653.1 Cr 5.8% -4.5% -32.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,131.0 Cr -0.7% -0.5% -3.1% Stock Analytics
DIVIS LABORATORIES ₹171,862.0 Cr 2.9% 1.8% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,254.0 Cr 1.5% 3.4% 12.4% Stock Analytics
CIPLA ₹121,198.0 Cr 0.2% -0.2% 0.4% Stock Analytics
DR REDDYS LABORATORIES ₹107,083.0 Cr 0.9% 4.8% -3.2% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

5.8%

-4.5%

-32.1%

SENSEX

1%

0.3%

6.7%


You may also like the below Video Courses